{"entity":{"id":"da-bn-late-diagnosis","kind":"bottleneck","name":"Late and uneven diagnosis","aka":[],"tldr":"Many people receive a dementia diagnosis late, or never receive a subtype. That blocks both care planning and trial entry.","summary":"Primary care time, fear, stigma, and limited memory-clinic capacity all delay a named diagnosis. Biomarker tests help only if someone is referred and the result will change care.","asOf":"2026-09-21","links":[{"label":"NIA","url":"https://www.nia.nih.gov/health/alzheimers-and-dementia"}],"tags":["dementia-atlas"],"related":[],"cancers":["dementia","alzheimers-disease"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"stage":"prevention-detection","severity":"major","metrics":[{"label":"Public education source on delayed recognition","value":"See NIA public pages","source":"NIA","url":"https://www.nia.nih.gov/health/alzheimers-and-dementia"}],"causes":["Symptoms dismissed as normal ageing.","Specialist waiting lists.","Biomarker tests concentrated in academic centres."],"currentEfforts":["Public symptom-awareness campaigns.","Blood biomarker triage research."],"successLooksLike":"People who want an assessment can get a timely clinical diagnosis and, where it changes care, a subtype discussion."},"route":"/bottlenecks/da-bn-late-diagnosis/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"},{"id":"dementia","kind":"cancer","name":"Dementia (umbrella)","route":"/diagnoses/dementia/"}],"idea":[{"id":"da-idea-blood-first-triage","kind":"idea","name":"Blood test before PET or lumbar puncture","route":"/ideas/da-idea-blood-first-triage/"}]}}